BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9612928)

  • 1. [Barrett esophagus with severe dysplasia in argon beam therapy].
    Maass S; Martin WR; Spiethoff A; Riemann JF
    Z Gastroenterol; 1998 Apr; 36(4):301-6. PubMed ID: 9612928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?
    Sharma P; Wani S; Rastogi A
    Gastrointest Endosc; 2007 Sep; 66(3):469-74. PubMed ID: 17725936
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
    Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
    Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia in Barrett's esophagus: limitations of current management strategies.
    Spechler SJ
    Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
    Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
    Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
    Byrne JP; Armstrong GR; Attwood SE
    Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local treatment of early cancer in short Barrett's esophagus by means of argon plasma coagulation: initial experience.
    May A; Gossner L; Günter E; Stolte M; Ell C
    Endoscopy; 1999 Aug; 31(6):497-500. PubMed ID: 10494693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
    Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC's of ablative techniques.
    Dumot JA; Greenwald BD
    Endoscopy; 2008 Dec; 40(12):1026-32. PubMed ID: 19065487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Watson TJ
    Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.